The stock market is highly volatile creating buying opportunities for new investors. Under the Radar Report recommends you buy shares right now that we believe can generate strong returns because they are good value. Which are which are the best shares to buy now? Choosing the right shares to buy The stock market turmoil can make it hard for you to choose which shares to buy now. It is important to have strong research when you invest in shares and buying the right stock for your investment goals is critical. However, it can take a long time to research every share you buy. Which shares to buy, hold and sell At Under the Radar Report we tell you exactly which shares to buy and when. Our team of expert analysts help you confidently choose which shares to Buy, Hold and Sell now. We provide 10 of the best shares to buy now each week which provides growth for our subscribers. We are currently recommending investors buy in small parcels and not chase stock prices, which has proven to be the right advice. Subscribe to Under the Radar Report. Acces this week's best Small Cap shares to buy. Free Access Here are three stocks to buy now 1. Hansen Technologies (HSN) This is a great stock to buy now and has been operating for almost 50 years. Hansen Technologies provides billing software for infrastructure companies and telcos. Its customers are Blue Chip and they stick. On top of that, the company only pays out of its earnings in dividends. 2. Freedom Foods (FNP) Freedom Foods is another great stock to buy now as consumers are increasingly looking to purchase dairy and plant-based products including milk, nutritional powders, cereals, muesli bars and nuts. The group said it is experiencing “strong demand for key products” and will continue to supply domestic and export markets. The group does have debt of almost $200 million but based on similar companies we think Freedom has enough room to move. 3. Medical Developments (MVP) This stock to buy now is on the riskier side. The specialist pharmaceutical company Medical Developments (MVP) is on the riskier side compared to the other two, but there is still a chance of achieving similar market penetration in non-opioid pain relief around the world that it has achieved in Australia, with its famed Green Whistle aka Penthrox. For a full list of stocks to buy now that we are recommending, sign up for our 14 day free trial. You can't afford to miss out.